# Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

> **NCT01118962** · PHASE2 · COMPLETED · sponsor: **UCB BIOSCIENCES, Inc.** · enrollment: 39 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Lacosamide

## Key facts

- **NCT ID:** NCT01118962
- **Lead sponsor:** UCB BIOSCIENCES, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2018-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01118962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01118962, "Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01118962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*